EDEL LIFE
DEAD

Serial Number

98513292

Owner

Saraiva, Maria Edelweiss

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EDEL LIFE Trademark

Serial Number: 98513292

EDEL LIFE is a trademark filed by Saraiva, Maria Edelweiss on April 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Saraiva, Maria Edelweiss (2 trademarks)

1711 Amazing Way - STE 213
OCOEE, FL 34761

Entity Type: 16

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment and prevention of hot flashes; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of rare menopause diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, psychotropics; Dermatological pharmaceutical products; Drug delivery agents in the form of a coating for cough that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; Flowers of sulfur for pharmaceutical purposes; Homeopathic pharmaceuticals for use in the treatment of menopause; Melissa water for pharmaceutical purposes; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis for pharmaceutical purposes; Royal jelly for pharmaceutical purposes; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Syrups for pharmaceutical purposes for the treatment of cough; Yeast extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 22, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 22, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 6, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 10, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2024 NWOS
NEW APPLICATION ENTERED
Apr 22, 2024 NWAP